Cleared Traditional

K900973 - VISUWELL(R) CHLAMYDIA

K900973 is an FDA 510(k) clearance for VISUWELL CHLAMYDIA, manufactured by Adi Diagnostics, Inc.. The device is a Class 1 Microbiology device with product code LJC cleared through the Traditional 510(k) pathway after a 74-day FDA review.

K900973 · Adi Diagnostics, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1990
Decision
74d
Days
Class 1
Risk

K900973 is an FDA 510(k) clearance for the VISUWELL(R) CHLAMYDIA. Classified as Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group) (product code LJC), Class I - General Controls.

Submitted by Adi Diagnostics, Inc. (Rexdale, Ontario, CA). The FDA issued a Cleared decision on May 15, 1990 after a review of 74 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3120 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Adi Diagnostics, Inc. devices

FDA 510(k) Submission Details - K900973

510(k) Number K900973 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 02, 1990
Decision Date May 15, 1990
Days to Decision 74 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
28d faster than avg
Panel avg: 102d · This submission: 74d
Pathway characteristics
Predicate-based equivalence.

LJC Device Classification - Class 1, General Controls

Product Code LJC Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3120
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LJC Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group)

All 53
Devices cleared under the same product code (LJC) and FDA review panel - the closest regulatory comparables to K900973.
QUIDEL CHLAMYDIA TEST
K901660 · Quidel Corp. · Jul 1990
PATHFINDER(TM) CHLAMYDIA MICROPLATE KIT
K902253 · Kallestad Diag, A Div. of Erbamont, Inc. · Jul 1990
KODAK SURECELL(TM) CHLAMYDIA CONTROL FLUID SET
K901934 · Eastman Kodak Company · Jun 1990
CHLAMYDIAZYME DIAGNOSTIC KIT
K900543 · Abbott Laboratories · May 1990
ADD'L USES FOR THE KODAK SURECELL CHLAMYDIA KIT
K900402 · Eastman Kodak Company · Mar 1990
CLEARVIEW CHLAMYDIA
K895280 · Unipath , Ltd. · Jan 1990